Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain of coronavirus not previously identified in humans. Globally, the number of confirmed cases and mortality rates of coronavirus disease 2019 (COVID-19) have risen dramatically. Currently, there are no FDA-approved antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yun Young, Park, Hee Ho, Park, Wooram, Kim, Hyelim, Jang, Jong Geol, Hong, Kyung Soo, Lee, Jae-Young, Seo, Hee Seung, Na, Dong Hee, Kim, Tae-Hyung, Choy, Young Bin, Ahn, June Hong, Lee, Wonhwa, Park, Chun Gwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583619/
https://www.ncbi.nlm.nih.gov/pubmed/33130319
http://dx.doi.org/10.1016/j.biomaterials.2020.120389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583619/
https://www.ncbi.nlm.nih.gov/pubmed/33130319
http://dx.doi.org/10.1016/j.biomaterials.2020.120389

Ejemplares similares